BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

IDev Technologies, Inc. 

1110 NASA Parkway, Suite 311

Houston  Texas  77058  U.S.A.
Phone: 281-333-1998 Fax: 281-333-4008


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Abbott Laboratories (ABT) Completes Acquisition of IDev Technologies, Inc. 8/21/2013 9:38:21 AM
IDev Technologies, Inc. Announces Results From Revascularization With Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients With Long Lesions 1/31/2013 8:48:58 AM
IDev Technologies, Inc. Release: Clinical Results for the Supera&#-174 Peripheral Stent System Highlighted at Leading Global Peripheral Intervention Course 1/25/2013 8:48:45 AM
IDev Technologies, Inc. Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent 10/23/2012 10:04:28 AM
IDev Technologies, Inc.'s Pivotal SUPERB Trial Demonstrates SUPERA® Stent Significantly Exceeds VIVA Criteria for One-Year Patency in Femoropopliteal Artery Disease 10/11/2012 10:23:31 AM
IDev Technologies, Inc. Announces Positive Two-Year Clinical Outcomes From Long Term Registry of the SUPERA® Stent in Femoropopliteal Artery Disease 10/11/2012 8:09:54 AM
IDev Technologies, Inc. Release: SUPERA® Stent Approved for Private Reimbursement in Australia 9/27/2012 12:02:23 PM
IDev Technologies, Inc. Introduces SurePath(TM) Guidewires 6/11/2012 10:13:01 AM
IDev Technologies, Inc. Strengthens Commercial Leadership 6/7/2012 9:55:39 AM
IDev Technologies, Inc. Release: Journal of Endovascular Therapy Publishes Two-Year Data On SUPERA(R) Stent Used in the Superficial Femoral Artery 12/15/2011 11:30:23 AM
1234